These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34965467)

  • 1. Synthesis, carbonic anhydrase enzyme inhibition evaluations, and anticancer studies of sulfonamide based thiadiazole derivatives.
    Bahadur A; Iqbal S; Muneer S; Alsaab HO; Awwad NS; Ibrahium HA
    Bioorg Med Chem Lett; 2022 Feb; 57():128520. PubMed ID: 34965467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
    Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
    Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides.
    Baranauskienė L; Hilvo M; Matulienė J; Golovenko D; Manakova E; Dudutienė V; Michailovienė V; Torresan J; Jachno J; Parkkila S; Maresca A; Supuran CT; Gražulis S; Matulis D
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):863-70. PubMed ID: 20166809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ureidobenzenesulfonamides as efficient inhibitors of carbonic anhydrase II.
    Serbian I; Schwarzenberger P; Loesche A; Hoenke S; Al-Harrasi A; Csuk R
    Bioorg Chem; 2019 Oct; 91():103123. PubMed ID: 31336306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-[2-(N-(Substituted phenyl)acetamide)]amino-1,3,4-thiadiazole-2-sulfonamides as Selective Carbonic Anhydrase II Inhibitors with Neuroprotective Effects.
    Jiang C; Shi J; Liao L; Zhang L; Liu J; Wang Y; Lao Y; Zhang J
    ChemMedChem; 2020 Apr; 15(8):705-715. PubMed ID: 32141184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII.
    Aday B; Ulus R; Tanç M; Kaya M; Supuran CT
    Bioorg Chem; 2018 Apr; 77():101-105. PubMed ID: 29353727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibition effects.
    Bülbül M; Saraçoğlu N; Küfrevioğlu OI; Ciftçi M
    Bioorg Med Chem; 2002 Aug; 10(8):2561-7. PubMed ID: 12057645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
    Altıntop MD; Sever B; Özdemir A; Kucukoglu K; Onem H; Nadaroglu H; Kaplancıklı ZA
    Bioorg Med Chem; 2017 Jul; 25(13):3547-3554. PubMed ID: 28511907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling.
    Ghorab MM; Ceruso M; Alsaid MS; Nissan YM; Arafa RK; Supuran CT
    Eur J Med Chem; 2014 Nov; 87():186-96. PubMed ID: 25255434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives.
    Zhang ZP; Zhong Y; Han ZB; Zhou L; Su HS; Wang J; Liu Y; Cheng MS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
    Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
    Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents.
    Peerzada MN; Khan P; Ahmad K; Hassan MI; Azam A
    Eur J Med Chem; 2018 Jul; 155():13-23. PubMed ID: 29852328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II.
    Mert S; Alım Z; İşgör MM; Beydemir Ş; Kasımoğulları R
    Bioorg Chem; 2016 Oct; 68():64-71. PubMed ID: 27454619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.
    Karalı N; Akdemir A; Göktaş F; Eraslan Elma P; Angeli A; Kızılırmak M; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(14):3714-3718. PubMed ID: 28545816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.